New AHA/ASA guideline on secondary stroke prevention
May 27, 2021
Identifying the cause of a first stroke or transient ischemic attack is key to developing strategies to prevent repeat events, the AHA/ASA says in an updated clinical practice guideline.
AHA reassures myocarditis rare after COVID vaccination, benefits overwhelm risks
May 24, 2021
As CDC investigates rare, mostly mild cases of myocarditis in adolescents and young adults given the Pfizer or Moderna vaccine, AHA emphasizes their effectiveness and strong safety record.
Reassuring data on impact of mild COVID-19 on the heart
May 12, 2021
“Mild COVID-19 left no measurable cardiovascular impact on LV structure, function, scar burden, aortic stiffness, or serum biomarkers.”
Nutritional support may be lifesaving in heart failure
May 6, 2021
Patients with high-risk chronic heart failure given individualized nutritional support in-hospital had lower mortality following discharge, a new analysis shows.
COVID-19 coaching program provides ‘psychological PPE’ for HCPs
May 5, 2021
Participating coaches are mental health clinicians with training in psychological first aid, resilience, and psychotherapy, said Dr. Benjamin Rosen.
COVID plus MI confers poor prognosis; 1 in 3 die in hospital
April 22, 2021
National registry data confirm the challenges and uniqueness of patients with STEMI and COVID-19, with atypical symptoms and ‘very high’ in-hospital mortality rates.
More evidence MIS-C is a delayed response to SARS-CoV-2
April 13, 2021
CDC analysis of the largest cohort of MIS-C cases in the United States to date shows three temporal peaks of diagnoses in the United States and further validates the “prevailing hypothesis that MIS-C is a postinfectious mediated disorder.”
FDA curbs use of COVID-19 convalescent plasma, citing new data
February 8, 2021
Only high-titer COVID-19 convalescent plasma can be used and only in hospitalized patients who are early in the disease course and those with impaired humoral immunity.
FDA clears first OTC rapid at-home COVID diagnostic test
December 16, 2020
Authorization of the Ellume COVID-19 Home Test is “a major milestone in diagnostic testing for COVID-19,” FDA Commissioner Stephen M. Hahn, MD, said.
COVID-19 neurologic fallout not limited to the severely ill
December 14, 2020
Patients with neurologic complications of COVID-19 are likely to require ongoing rehabilitation, even after they leave the hospital.